Clinical trials
Terminated Retinal Vein Occlusion trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
24 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 2 |
| 2006 | 2 |
| 2007 | 2 |
| 2009 | 2 |
| 2010 | 2 |
| 2013 | 4 |
| 2015 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 24 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Clearside Biomedical, Inc. | 2 |
| Novartis Pharmaceuticals | 2 |
| Alimera Sciences | 1 |
| Asociación para Evitar la Ceguera en México | 1 |
| David M. Brown, M.D. | 1 |
| Duke University | 1 |
| Fovea Pharmaceuticals SA | 1 |
| Helse Stavanger HF | 1 |
| Insel Gruppe AG, University Hospital Bern | 1 |
| Johns Hopkins University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Retinal Vein Occlusion | 24 |
| Macular Edema | 11 |
| Diabetic Retinopathy | 4 |
| Macular Degeneration | 3 |
| Vision Disorders | 3 |
| Retinal Diseases | 2 |
| Bites and Stings | 1 |
| Central Serous Chorioretinopathy | 1 |
| Communicable Diseases | 1 |
| Eye Diseases | 1 |
Trials
Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.